| Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice L Opazo-Ríos, M Soto-Catalán, I Lázaro, A Sala-Vila, L Jiménez-Castilla, ... | 10 | 2022 |
| Kidney microRNA expression pattern in type 2 diabetic nephropathy in BTBR Ob/Ob mice L Opazo-Ríos, A Tejera-Muñoz, M Soto Catalan, V Marchant, C Lavoz, ... Frontiers in Pharmacology 13, 778776, 2022 | 8 | 2022 |
| MicroRNA‐135a‐5p reduces P2X7‐dependent rise in intracellular calcium and protects against excitotoxicity D Reigada, AÁ Calderón‐García, M Soto‐Catalán, M Nieto‐Díaz, ... Journal of Neurochemistry 151 (1), 116-130, 2019 | 7 | 2019 |
| The synthetic flavonoid hidrosmin improves endothelial dysfunction and atherosclerotic lesions in diabetic mice L Jiménez-Castilla, L Opazo-Ríos, G Marin-Royo, M Orejudo, ... Antioxidants 11 (12), 2499, 2022 | 1 | 2022 |
| Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease M Soto-Catalán, L Opazo-Ríos, H Quiceno, I Lázaro, JA Moreno, ... International Journal of Molecular Sciences 25 (5), 2961, 2024 | | 2024 |
| P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE L Opazo-Ríos, M Soto-Catalán, I Lázaro, A Sala-Vila, C Pérez-Gallardo, ... Annals of Hepatology 28, 100906, 2023 | | 2023 |
